Clinical controversies in vitamin D: 25(OH)D measurement, target concentration, and supplementation

J Clin Densitom. 2013 Oct-Dec;16(4):402-8. doi: 10.1016/j.jocd.2013.08.006.

Abstract

Despite a plethora of recent research and systematic reviews of available data, controversy continues to surround the definition of optimal vitamin D status, the daily intake needed, and the potential adverse health consequences of "insufficiency." Efforts to standardize vitamin D measurement and improve understanding of the physiologic consequences of other vitamin D metabolites such as 3-epi and 24,25(OH)2D (and potentially other vitamin D compounds) are needed. Currently, measurement of circulating 25(OH)D is accepted as the approach to define an individual's vitamin D status. However, existing 25(OH)D assays may include other vitamin D metabolites such as the 3-epimer of 25(OH)D and 24,25(OH)2D. It seems unlikely that the controversy will soon be resolved.

Keywords: 25-Hydroxyvitamin D; measurement; supplementation; vitamin D.

Publication types

  • Review

MeSH terms

  • Bone Density Conservation Agents / pharmacokinetics
  • Dietary Supplements*
  • Humans
  • Osteoporosis / blood
  • Osteoporosis / etiology
  • Osteoporosis / therapy*
  • Vitamin D / pharmacokinetics*
  • Vitamin D Deficiency / blood
  • Vitamin D Deficiency / complications
  • Vitamin D Deficiency / therapy*

Substances

  • Bone Density Conservation Agents
  • Vitamin D